How to Use FOXO4-DRI
Complete guide to FOXO4-DRI dosing, administration, timing, and protocol recommendations.
Quick Overview
A senolytic peptide designed to selectively eliminate senescent 'zombie' cells by disrupting the FOXO4-p53 interaction. Shows promise for restoring tissue function in aging, including kidney health restoration.
Dosing Guidelines
Common Dose
2-10 mg every other day for 3 doses (one cycle)
Frequency
3 doses every other day, 1-3 cycles per year
Dose Range
2-25 mg per injection, 6-75 mg total per cycle
Note: Senolytic peptide - used in short intermittent cycles, not daily. Mouse studies used 5 mg/kg x3 doses (translates to ~25 mg/dose for 60kg human). Biohacker protocols vary: some use 2-3 mg every other day for 6 days, others use higher 10-25 mg doses for 3 injections. Lower-dose protocols (300-500 mcg daily for weeks) also reported. Subcutaneous injection most common. Side effects may include injection site reactions, fatigue, muscle soreness, nausea.
Administration Method
Subcutaneous injection (community), IV/IP in animal studies
Best Time to Take
Per research protocol
FOXO4-DRI is typically administered in intermittent treatment cycles rather than daily dosing. The peptide triggers apoptosis in senescent cells, which then need time for clearance and tissue regeneration.
Protocol Duration
1 cycle = 3 doses over 5-6 days, repeat 1-3x yearly
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Generally well-tolerated in animal studies
- •Injection site reactions (burning, itching)
- •Fatigue
- •Muscle soreness
- •Nausea
Frequently Asked Questions
What is the recommended dose for FOXO4-DRI?
2-10 mg every other day for 3 doses (one cycle)
How do you administer FOXO4-DRI?
Subcutaneous injection (community), IV/IP in animal studies
When is the best time to take FOXO4-DRI?
Per research protocol
How long should you use FOXO4-DRI?
1 cycle = 3 doses over 5-6 days, repeat 1-3x yearly
This information is for educational purposes only. Always consult with a healthcare professional before using any peptide. Dosing information is based on research literature and community reports, not medical advice.